跳至主要内容
临床试验/NCT04586166
NCT04586166招募中不适用

SASS: Randomized Trial of Single-incision Versus Retropubic Mid-Urethral Sling (Solyx) for Concomitant Management of Stress Urinary Incontinence During Minimally Invasive Sacrocolpopexy

Wake Forest University Health Sciences12 个研究点 分布在 2 个国家目标入组 180 人开始时间: 2020年12月23日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
180
试验地点
12
主要终点
Number of participants with subjectively bothersome stress incontinence

研究概览

简要总结

SASS (Single-incision Versus Retropubic Mid-Urethral Sling (Solyx) for SUI During Minimally Invasive Sacrocolpopexy) will be a multicenter, prospective, randomized, single-blind non-inferiority trial.

详细描述

SASS aims to compare the efficacy of a single-incision (SIS) versus a retropubic mid-urethral sling (RP) placed at the time of minimally invasive sacrocolpopexy in women with pelvic organ prolapse and objectively confirmed stress urinary incontinence (SUI).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

盲法说明

Participants will be masked during the five-year follow-up period. Precautions will be taken to minimize unmasking the study groups. Since RP (retropubic) slings require two suprapubic stab incisions, identical sham incision will also be performed in the SIS (Single-Incision Sling) group.

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • At least 21 years of age
  • Vaginal bulge symptoms as indicated by an affirmative response of >1 to question 3 of the PFDI-SF20
  • POP ≥ stage II according to the pelvic organ prolapse quantification (POP-Q) system45, with evidence of apical descent
  • Women being considered for minimally invasive sacrocolpopexy (with or without concomitant hysterectomy)
  • Objective SUI: positive standardized cough stress test on clinical examination or on urodynamic study with reduced prolapse
  • Understanding and acceptance of the need to return for all scheduled follow-up visits and willing to complete study questionnaires
  • Able to give informed consent

排除标准

  • Prior surgery for stress urinary incontinence including mid-urethral sling; Burch/MMK; fascial pubovaginal sling (autologous, xenograft or allograft); and urethral bulking injection
  • Any serious disease, or chronic condition, that could interfere with the study compliance
  • Unwilling to have a synthetic sling
  • Untreated and unresolved urinary tract infection
  • Poorly-controlled diabetes mellitus (HgbA1c > 9 within 3 months of surgery date)
  • Neurogenic bladder/ pre-operative self-catheterization
  • Elevated post-void residual/PVR (>150 ml) that does not resolve with prolapse reduction testing (pessary, prolapse reduced uroflow or micturition study)
  • Prior pelvic radiation
  • Inflammatory bowel disease
  • Current genitourinary fistula or urethral diverticulum
  • Planned concomitant bowel related surgery including sphincteroplasty and perineal rectal prolapse surgery, rectovaginal fistula repair, hemorrhoidectomy
  • Pregnant or Planning to Conceive
  • Incarcerated

结局指标

主要结局

Number of participants with subjectively bothersome stress incontinence

时间窗: 5 years after surgery

Measured by a positive response of \> 1 to Question 17 on Pelvic Floor Distress Inventory short form-20 (PFDI-20). Response scale from 0 to 4. Symptoms Not Present = NO 0 = not present Symptoms Present = YES, scale of bother: 1 = not at all, 2 = somewhat, 3 = moderately, 4 = quite a bit

次要结局

  • Pelvic Organ Prolapse/Urinary Incontinence Sexual Functioning Short Form (PISQ-IR)(Baseline, Surgery, Post Op: week 2, week 6, year 1, year 2, year 3, and year 5)
  • Pelvic Floor Impact (PFIQ-SF7)(Baseline, Surgery, Post Op: week 2, week 6, year 1, year 2, year 3, and year 5)
  • Assessment of post-void residual (PVR) volume(Baseline, Surgery, Post Op: week 2, week 6, year 1, year 2, year 3, and year 5)
  • Number of Participants needing Retreatment(6 month up to 5 year post-surgery)
  • Number of Participants needing bladder drainage(beyond 6 weeks post-surgery)
  • VAS (Visual Analogue Scale Surgeon ease of Use)(Baseline, Surgery, Post Op: week 2, week 6, year 1, year 2, year 3, and year 5)
  • Patient Global Impression of Improvement (PGI-I)(Baseline, Surgery, Post Op: week 2, week 6, year 1, year 2, year 3, and year 5)
  • Pelvic Floor Distress Inventory (PFDI-SF20)(Baseline, Surgery, Post Op: week 2, week 6, year 1, year 2, year 3, and year 5)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (12)

Loading locations...

相似试验